These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36345069)

  • 1. Half-sandwich ruthenium(II), rhodium(III) and iridium(III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities.
    Nongpiur CGL; Verma AK; Singh RK; Ghate MM; Poluri KM; Kaminsky W; Kollipara MR
    J Inorg Biochem; 2023 Jan; 238():112059. PubMed ID: 36345069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
    Kacsir I; Sipos A; Bényei A; Janka E; Buglyó P; Somsák L; Bai P; Bokor É
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA/protein, molecular docking and antitumor activity.
    Paitandi RP; Gupta RK; Singh RS; Sharma G; Koch B; Pandey DS
    Eur J Med Chem; 2014 Sep; 84():17-29. PubMed ID: 25014746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of various lipophilic substituents on ruthenium(II), rhodium(III) and iridium(III) salicylaldimine-based complexes: synthesis, in vitro cytotoxicity studies and DNA interactions.
    Cassells I; Stringer T; Hutton AT; Prince S; Smith GS
    J Biol Inorg Chem; 2018 Jul; 23(5):763-774. PubMed ID: 29846816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing Anticancer Activity with Phosphine Ligation in Zwitterionic Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes.
    Hu X; Guo L; Liu M; Zhang Q; Gong Y; Sun M; Feng S; Xu Y; Liu Y; Liu Z
    Inorg Chem; 2022 Dec; 61(49):20008-20025. PubMed ID: 36426422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
    Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
    Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
    Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
    J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
    Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
    J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
    Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
    Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application.
    Ji C; Dong R; Zhang P; Tao R; Wang X; Dai Q; Liu X; Yuan XA; Zhang S; Yue M; Liu Z
    J Inorg Biochem; 2024 Aug; 257():112586. PubMed ID: 38728860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
    Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
    Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.
    Koch V; Meschkov A; Feuerstein W; Pfeifer J; Fuhr O; Nieger M; Schepers U; Bräse S
    Inorg Chem; 2019 Dec; 58(23):15917-15926. PubMed ID: 31714764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.
    Govender P; Riedel T; Dyson PJ; Smith GS
    Dalton Trans; 2016 Jun; 45(23):9529-39. PubMed ID: 27193373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
    Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.